Biomarin Pharmaceutical Inc (BMRN)
Number of days of payables
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Payables turnover | — | — | — | — | — | |
| Number of days of payables | days | — | — | — | — | — |
December 31, 2024 calculation
Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ —
= —
The data provided for Biomarin Pharmaceutical Inc's number of days of payables is missing for the years December 31, 2020 through December 31, 2024. Without this information, it is not possible to analyze the company's performance in terms of its payables turnover or payment terms with suppliers over these years. This missing data hinders a comprehensive assessment of Biomarin's efficiency in managing its accounts payable and cash flow relationships.
Peer comparison
Dec 31, 2024
Company name
Symbol
Number of days of payables
Biomarin Pharmaceutical Inc
BMRN
—
Abbott Laboratories
ABT
49.95
AbbVie Inc
ABBV
29.64
Alkermes Plc
ALKS
18.68
Amphastar P
AMPH
31.10
ANI Pharmaceuticals Inc
ANIP
33.22
Arcus Biosciences Inc
RCUS
43.80
Bristol-Myers Squibb Company
BMY
41.38
Catalent Inc
CTLT
38.44
Catalyst Pharmaceuticals Inc
CPRX
24.74
Collegium Pharmaceutical Inc
COLL
7.94